Vilin Bio Med Ltd (VILINBIO) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: VILINBIO | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

Vilin Bio Med Ltd (VILINBIO) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: VILINBIO | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Vilin Bio Med

Based on:

M-Cap below 100cr DeciZen not available

Vilin Bio Med stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
121.71
Market Cap:
27.2 Cr.
52-wk low:
0
52-wk high:
0

Is Vilin Bio Med Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Vilin Bio Med: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vilin Bio Med Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 5.1%4.9%4.3%17.2%4.5%4.2%-
Value Creation
Index
-0.6-0.7-0.70.2-0.7-0.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 16.811.711.212.315.814.815
Sales YoY Gr.--30.3%-4.4%9.8%28.4%-6.3%-
Adj EPS 0.40.301.30.10.20.2
YoY Gr.--16.7%-86.7%3025%-90.4%33.3%-
BVPS (₹) 8.88.9910.716.416.516.5
Adj Net
Profit
0.30.301.30.20.20
Cash Flow from Ops. -1.5-10.2-1.7-7.40.2-
Debt/CF from Ops. -3.1-5.525.4-3-0.911.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA-2.5%9.7%-6.3%
Adj EPS NA-15%58.7%33.3%
BVPSNA13.5%22.6%1%
Share Price - - - -2.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
4.13.40.513.8111
Op. Profit
Mgn %
6.58.76.820.95.25.3NAN
Net Profit
Mgn %
1.82.10.310.111.51.5
Debt to
Equity
0.60.80.70.50.30.1-
Working Cap
Days
03713884154756140
Cash Conv.
Cycle
02522962041502130

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Vilin Bio Med Ltd.

Standalone Consolidated
TTM EPS (₹) 0.2 -
TTM Sales (₹ Cr.) 14.8 -
BVPS (₹.) 16.5 -
Reserves (₹ Cr.) 9 -
P/BV 1.18 -
PE 121.71 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 27.2
Equity (₹ Cr.) 14
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Vilin Bio Med:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Vilin Bio Med - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Vilin Bio Med

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales16.8111.7211.2112.3115.8014.81
Operating Expenses 15.9110.8810.459.7414.9914.02
Manufacturing Costs0.330.330.22000
Material Costs13.729.048.877.1713.0113.47
Employee Cost 1.200.910.850.780.800.30
Other Costs 0.670.600.511.791.180.26
Operating Profit 0.900.830.772.570.820.79
Operating Profit Margin (%) 5.3%7.1%6.8%20.9%5.2%5.3%
Other Income 0.010.0300.020.320.47
Interest 0.410.440.510.650.790.85
Depreciation 0.310.260.220.170.130.10
Exceptional Items 000000
Profit Before Tax 0.190.160.041.780.230.31
Tax 0.030.040.010.540.060.08
Profit After Tax 0.160.120.031.250.160.22
PAT Margin (%) 1.0%1.0%0.3%10.1%1.0%1.5%
Adjusted EPS (₹)0.20.20.01.30.10.2
Dividend Payout Ratio (%)0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 7.247.367.4010.6822.8423.06
Share Capital 3.303.303.309.9513.9513.95
Reserves 3.944.064.100.738.899.11
Minority Interest000000
Debt4.535.525.304.936.832.57
Long Term Debt01.020.730.430.210
Short Term Debt4.534.504.574.506.622.57
Trade Payables1.860.820.641.191.951.39
Others Liabilities 0.370.200.220.880.780.70
Total Liabilities 14.0113.8913.5617.6832.4027.73

Fixed Assets

Gross Block2.131.879.369.389.399.39
Accumulated Depreciation007.717.8788.11
Net Fixed Assets 2.131.871.651.511.381.28
CWIP 000001.57
Investments 000000
Inventories2.112.062.280.884.474.41
Trade Receivables7.277.657.795.605.686.31
Cash Equivalents 0.070.050.040.036.050.06
Others Assets 2.432.271.809.6514.8214.10
Total Assets 14.0113.8913.5617.6832.4027.73

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -1.46-10.21-1.66-7.420.22
PBT 0.190.160.041.780.230.31
Adjustment 0.310.260.220.170.920.95
Changes in Working Capital -1.93-1.38-0.05-3.07-8.19-0.5
Tax Paid -0.04-0.04-0.01-0.54-0.05-0.07
Cash Flow From Investing Activity -0.0200-0.030.32-1.11
Capex -0.0200-0.03-0-1.57
Net Investments 000000
Others 00000.320.47
Cash Flow From Financing Activity 1.510.98-0.221.688.87-5.10
Net Proceeds from Shares 0002.04120
Net Proceeds from Borrowing 01.02-0.28-0.29-0.22-0.21
Interest Paid 0000-0.79-0.85
Dividend Paid 000000
Others 1.51-0.030.07-0.07-2.12-4.05
Net Cash Flow 0.03-0.02-0.01-01.77-5.99

Finance Ratio

PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)2.241.660.4613.780.970.97
ROCE (%)5.094.894.3117.174.474.16
Asset Turnover Ratio1.20.840.820.790.630.49
PAT to CFO Conversion(x)-9.13-8.337-1.33-46.381
Working Capital Days
Receivable Days158232251198130148
Inventory Days4665714762109
Payable Days495430474445

Vilin Bio Med Ltd Stock News

Vilin Bio Med Ltd FAQs

The current trading price of Vilin Bio Med on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Vilin Bio Med stood at ₹27.20.
The latest P/E ratio of Vilin Bio Med as of 31-Dec-1969 is 121.7.
The latest P/B ratio of Vilin Bio Med as of 31-Dec-1969 is 1.18.
The 52-week high of Vilin Bio Med is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vilin Bio Med is ₹14.81 ( Cr.) .

About Vilin Bio Med Ltd

The company was originally incorporated as a public limited company under the Companies Act, 1956 pursuant to a certificate of incorporation issued by the Registrar of Companies, Andhra Pradesh, Hyderabad dated June 29, 2005 with the name ‘Vilin Bio Med Limited’. It received a certificate of commencement of business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad.

The company is engaged in domestic business of manufacturing Pharmaceuticals products and the Manufacturing Unit is located in Roorkee, in the State of Uttarakhand. In order to maintain its competitiveness and to further the cause of Healthcare, the company has laid a R&D Foundation and state of the art Manufacturing Facility in Roorkee. Its Sales Strategy is to sell its products in bulk to Pharmaceuticals Manufacturers, Marketers and Traders, who in turn provide the channel for sales to customers. Its products are primarily used by other pharmaceutical companies and traders, who ultimately will market it to the distributors and retail customers. It do not sell its products under any brand name.

Vilin Bio Med is engaged in the manufacturing of pharmaceuticals formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non Beta Lactam tablets and Capsules & Nutritional Food supplements. Its Promoters, Mr. Sadhanala Venkata Rao, Mr. Viswa Prasad Sadhanala, Mr. D. Srinivasa Reddy, and Mr. Anuj Bajpai are actively involved in the day-to-day business. Its Promoters are the guiding force behind the Strategic Decisions of the company. Their Industry Knowledge and understanding of the current market situation enables it to improve its geographic horizon and market presence.

Business area of the company

The company is engaged in the manufacturing of pharmaceuticals formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non Beta Lactam tablets and Capsules & Nutritional Food supplements.

Products of the company

  • Cardiovascular drugs
  • Musculo-Skeletal drugs
  • Antibiotics drugs
  • Central nervous system drugs
  • Alimentary sytem drugs
  • Genito-Urinary tract drugs
  • Respiratory system & anti-allergics drugs
  • Anti- diabetic drugs
  • Multi-vitamins, minerals & amino acids supplements
  • Miscellaneous drugs
  • Liquid orals

History and milestone

  • 2005: Company Incorporation.
  • 2006: First Commercial production.
  • 2007: Expansion of Phase 2 for Beta Lactum facility with 16000 sft for Tablet, Capsule and Dry Syrup sections.
  • 2010: It has received more than 1000 molecules Drug Approvals with different strengths in therapeutics of Diabetic, Neuro and Cardio.
  • 2012: 120 different styles of Packing’s including physician sample packs to meet all types packing requirements in the market.
  • 2014: Added the Sachet section in Non-Beta Lactum facility.
  • 2015: More than 20 different Punches in different dimensions of the tablet including size and volume to meet all the customer requirements.
  • 2021: New Promoters are inducted to strengthen the Management of the Company
  • 2022: Company appointed Professionals on the Board to strengthen the Board and Corporate Governance.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×